|Craig J. Hoesley, MD
Medical School: University of South Florida
Residency: Internal Medicine, UAB
Fellowship: Infectious Diseases, UAB
Dr. Hoesley received his medical degree from the University of South Florida and completed his internship, internal medicine residency, and infectious disease fellowship at the University of Alabama at Birmingham. He joined the UAB faculty in 1998 and served as the internal medicine clerkship director for 7 years prior to becoming the Associate Dean for Undergraduate Medical Education in July 2008. In this role, Dr. Hoesley provides oversight to the Office of Undergraduate Medical Education which is charged with the development, administration, and evaluation of the preclinical and clinical curriculum in the School of Medicine. His research interests include the development of a safe and effective microbicide to prevent sexual transmission of HIV. He is the UAB site leader for the NIH-funded Microbicide Trials Network. Dr. Hoesley is the current Chair of the University Hospital Pharmacy and Therapeutic Committee.
Craig Hoesley, MD, continues to lead efforts to find safe and effective HIV-prevention methods with a new study in female U.S. teens. The latest study is evaluating the safety and acceptability of a vaginal ring containing an antiretroviral (ARV) drug called dapivirine among teenage girls ages 15-17 in the United States. The study is being conducted at six sites to collect critically important information in support of the ring’s potential regulatory approval as a method for preventing HIV in women. Read the UAB story here.